Cargando…
Characteristics of Patients in SPCG-15—A Randomized Trial Comparing Radical Prostatectomy with Primary Radiotherapy plus Androgen Deprivation Therapy in Men with Locally Advanced Prostate Cancer
BACKGROUND: There is no high-grade evidence for surgery as primary treatment for locally advanced prostate cancer. The SPCG-15 study is the first randomized trial comparing surgical treatment with radiotherapy. OBJECTIVE: To describe the baseline characteristics of the first 600 randomized men in th...
Autores principales: | Gongora, Magdalena, Stranne, Johan, Johansson, Eva, Bottai, Matteo, Thellenberg Karlsson, Camilla, Brasso, Klaus, Hansen, Steinbjørn, Jakobsen, Henrik, Jäderling, Fredrik, Lindberg, Henriette, Lilleby, Wolfgang, Meidahl Petersen, Peter, Mirtti, Tuomas, Olsson, Mats, Rannikko, Antti, Røder, Martin Andreas, Henrik Vincent, Per, Akre, Olof |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9257646/ https://www.ncbi.nlm.nih.gov/pubmed/35813256 http://dx.doi.org/10.1016/j.euros.2022.04.013 |
Ejemplares similares
-
Effectiveness of Docetaxel for Metastatic Hormone-sensitive Prostate Cancer in Clinical Practice
por: Lendorf, Maria Elisabeth, et al.
Publicado: (2021) -
Risk of Recurrent Disease 6 Years After Open or Robotic-assisted Radical Prostatectomy in the Prospective Controlled Trial LAPPRO
por: Nyberg, Martin, et al.
Publicado: (2020) -
Prostate Cancer–specific Survival After Radical Prostatectomy Is Improved Among Metformin Users but Not Among Other Antidiabetic Drug Users
por: Joentausta, Roni M., et al.
Publicado: (2021) -
PCASTt/SPCG-17—a randomised trial of active surveillance in prostate cancer: rationale and design
por: Ahlberg, Mats Steinholtz, et al.
Publicado: (2019) -
Low Blood Levels of LRG1 Before Radical Prostatectomy Identify Patients with High Risk of Progression to Castration-resistant Prostate Cancer
por: Guldvik, Ingrid Jenny, et al.
Publicado: (2022)